Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapy.

Phung YT, Barbone D, Broaddus VC, Ho M.

J Cancer. 2011;2:507-14. Epub 2011 Oct 13.

2.

The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy.

Xiang X, Phung Y, Feng M, Nagashima K, Zhang J, Broaddus VC, Hassan R, Fitzgerald D, Ho M.

PLoS One. 2011 Jan 31;6(1):e14640. doi: 10.1371/journal.pone.0014640.

3.

Multicellular tumor spheroids as an in vivo-like tumor model for three-dimensional imaging of chemotherapeutic and nano material cellular penetration.

Ma HL, Jiang Q, Han S, Wu Y, Cui Tomshine J, Wang D, Gan Y, Zou G, Liang XJ.

Mol Imaging. 2012 Nov-Dec;11(6):487-98.

4.

Human neuroendocrine tumor cell lines as a three-dimensional model for the study of human neuroendocrine tumor therapy.

Wong C, Vosburgh E, Levine AJ, Cong L, Xu EY.

J Vis Exp. 2012 Aug 14;(66):e4218. doi: 10.3791/4218.

5.

The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.

Chitcholtan K, Sykes PH, Evans JJ.

J Transl Med. 2012 Mar 6;10:38. doi: 10.1186/1479-5876-10-38.

6.

Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro.

Green SK, Francia G, Isidoro C, Kerbel RS.

Mol Cancer Ther. 2004 Feb;3(2):149-59.

7.

Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors.

Kerbel RS, St Croix B, Florenes VA, Rak J.

Hum Cell. 1996 Dec;9(4):257-64. Review.

PMID:
9183656
8.

Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents.

Graham CH, Kobayashi H, Stankiewicz KS, Man S, Kapitain SJ, Kerbel RS.

J Natl Cancer Inst. 1994 Jul 6;86(13):975-82.

PMID:
8007019
9.
10.

Bcl-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids.

Yang TM, Barbone D, Fennell DA, Broaddus VC.

Am J Respir Cell Mol Biol. 2009 Jul;41(1):14-23. doi: 10.1165/rcmb.2008-0320OC. Epub 2008 Dec 18.

11.

Diversity of cell-mediated adhesions in breast cancer spheroids.

Ivascu A, Kubbies M.

Int J Oncol. 2007 Dec;31(6):1403-13.

PMID:
17982667
13.

Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.

Mitrofanova E, Hagan C, Qi J, Seregina T, Link C Jr.

Anticancer Res. 2003 May-Jun;23(3B):2397-404.

PMID:
12894520
14.

1H NMR investigations of tumor spheroids grown from a human glioma biopsy or from a human malignant glioma cell line.

Kotitschke K, Tonn JC, Goldbrunner R, Bogdahn U, Haase A.

J Magn Reson B. 1995 Oct;109(1):39-43.

PMID:
8581307
15.

Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells.

Croix BS, Rak JW, Kapitain S, Sheehan C, Graham CH, Kerbel RS.

J Natl Cancer Inst. 1996 Sep 18;88(18):1285-96.

16.

Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids.

Barbone D, Yang TM, Morgan JR, Gaudino G, Broaddus VC.

J Biol Chem. 2008 May 9;283(19):13021-30. doi: 10.1074/jbc.M709698200. Epub 2008 Mar 13.

17.

Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.

Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM.

Cancer Res. 1992 Oct 15;52(20):5713-9.

18.

Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids.

Nicholson KM, Bibby MC, Phillips RM.

Eur J Cancer. 1997 Jul;33(8):1291-8.

PMID:
9301458
19.
20.

Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects.

Kikuchi T, Ohnuma T, Holland JF, Spitler LE.

Cancer Immunol Immunother. 1992;35(5):302-6.

PMID:
1394334
Items per page

Supplemental Content

Write to the Help Desk